Latest Asx Company Filings News

ECS Botanics reports a 20% quarterly surge in direct-to-consumer sales and a record medicinal cannabis harvest, supported by an expanded loan facility to fuel further growth.

Charger Metals NL reported steady progress in its June 2025 quarterly activities, advancing lithium exploration at the Lake Johnston Project in Western Australia with funding support from Rio Tinto Exploration. The company awaits further drilling permits to continue testing promising targets.

African Gold Ltd has kicked off its largest-ever 40,000-metre drilling program at the Didievi Gold Project in Côte d'Ivoire, aiming to build on a recently defined near-surface 989,000-ounce gold resource.

Australian Foundation Investment Company Limited (AFIC) reported a $285 million net profit for FY2025, declaring a fully franked 14.5c final dividend plus a 5c special dividend tied to capital gains from portfolio adjustments.

Lachlan Star Limited reports promising high-grade gold intersections from recent drilling at its Killaloe Gold Project in Western Australia, alongside strategic expansion of its exploration tenure.

Gorilla Gold reports impressive high-grade gold intercepts from its Mulwarrie Project in Western Australia, setting the stage for a significant resource upgrade expected this quarter.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

DXN Limited reported a robust Q4 FY25 with 51% revenue growth, securing key contracts and completing a strategic property acquisition that strengthens its modular data centre footprint.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.

Elanor Investors Group announces a $125 million recapitalisation through an expanded alliance with Rockworth Capital Partners, including the acquisition of Singapore’s Firmus Capital and a strategic shift towards Pan-Asian real estate markets.